Betta Pharmaceuticals Co., Ltd. (SHE:300558)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Pharmaceutical Manufacturing	2.89B	2.46B	2.38B	2.25B	1.87B
Pharmaceutical Manufacturing Growth	17.74%	3.35%	5.82%	20.08%	20.36%
Total	2.89B	2.46B	2.38B	2.25B	1.87B
Total Growth	17.74%	3.35%	5.82%	20.08%	20.36%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
China	2.25B	1.86B
China Growth	20.48%	19.94%
Foreign	411.08K	6.52M
Foreign Growth	-93.70%	-
Total	2.25B	1.87B
Total Growth	20.08%	20.36%

Source: S&P Global Market Intelligence.